Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

Overview of attention for article published in New England Journal of Medicine, December 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 80 news outlets
blogs: 7 blogs
policy: 4 policy sources
twitter: 338 X users
patent: 136 patents
facebook: 15 Facebook pages

googleplus: 2 Google+ users
reddit: 6 Redditors
q&a: 1 Q&A thread
video: 1 YouTube creator
guideline: 12 clinical guideline sources
podcasts: 2 podcasts

Readers on

mendeley: 3470 Mendeley
citeulike: 3 CiteULike

So far, Altmetric has seen 6 Reddit threads by 6 users.

With limitation of not being a CAR-T specialist The...

User Erel_Joffe_MD, in the lymphoma subreddit, 27 Dec 2021

With limitation of not being a CAR-T specialist ... The rate of neurotoxicity is different between various CAR-T products. If…

FDA’s [list of approved gene...

User WhiteDomino, in the conspiracy subreddit, 06 Oct 2021

FDA’s [list of approved gene therapies](https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/approved-cell…

Please help explain some weird statistics

User KayDang, in the Oncology: medicine and science subreddit, 27 Dec 2017

Break Through in CAR T-Cell Immunotherapy Shows Efficacy in Phase 1 Trial for Large B-Cell Lymphoma

User autotldr, in the autotldr subreddit, 11 Dec 2017

This page shows the most recent Reddit threads that mention this research output. Click here to find out how to access more activity, including 2 additional Reddit threads.